Malik Peiris of the University of Hong Kong found that antibodies to a vaccine made from the main surface protein of SARS allow the virus to enter immune cells, where they can trigger a destructive immune attack on the lung.
«When inflammation persists beyond its intended borders and purpose, however, the immune system mistakenly attacks normal cells, and the process that ordinarily heals becomes destructive.